scholarly journals A randomized, double-blind, placebo-controlled trial of a COX-2 inhibitor (Rofecoxib) in patients undergoing coronary artery bypass surgery

2006 ◽  
Vol 5 (2) ◽  
pp. 101-104 ◽  
Author(s):  
P.-S. Wong
Sign in / Sign up

Export Citation Format

Share Document